Financial-disclosure law going into effect for drug-, device-makers

07/28/2013 | Star Tribune (Minneapolis-St. Paul, Minn.)

U.S. drug and device companies on Thursday must begin keeping records of payments made to hospitals and doctors as part of new financial disclosure rules included in the Affordable Care Act. Industry stakeholders hope the information will allay fears that these relationships adversely affect patient outcomes or result in unethical behavior.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY